What kind of new drugs will we get in the future and why?
Lammintausta, R.
Duodecim; Laaketieteellinen Aikakauskirja 116(24): 2807-2808
2000
ISSN/ISBN: 0012-7183 PMID: 12077884 Document Number: 520501
Document emailed within 1 workday
Related Documents
Tomioka, H.; Tada, A. 2010: Can we have adequate chemotherapy regimens for tuberculosis in the future? Current status and future prospects for development of new antituberculosis drugs Kekkaku: 85(2): 113-123Baldini, E.; Prochilo, T. 2004: The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: what kind of evidence? I Suppli di Tumori: Official Journal of Societa Italiana di Cancerologia . 3(4): S79-S80
Endo, I. 2017: Calcilytic drugs:Feature and future Clinical Calcium 27(4): 547-552
Bourin, M.; Bradwejn, J. 1992: Cholecystokinin antagonists: anxiolytic drugs of the future Pathologie-Biologie 40(3): 215-217
Pelt, J.M. 1975: Drugs: exploration of the future or return to prehistory Il Farmaco; Edizione Pratica 30(12): 585-604
D'Angelo, A.; Crippa, L.; Agazzi, A.; Della Valle, P.; Anzalone, N.; Garlando, A.M.; D'Angelo, S.V. 1995: Oral anticoagulants: old drugs with a promising future Haematologica 80(2 Suppl): 92-101
Perbeck, L. 1998: Angiogenesis-inhibiting drugs--a future therapeutic option Nordisk Medicin 113(9): 297-298; 316
Chung, K.Fan. 2003: Current and future prospects for drugs to suppress cough Idrugs: the Investigational Drugs Journal 6(8): 781-786
Henderson, G.L. 1988: Designer drugs: past history and future prospects Journal of Forensic Sciences 33(2): 569-575
Whitney, H.A.; Covington, T.R. 1971: The future impact of clinical pharmacy on parenteral drugs and the industry Bulletin of the Parenteral Drug Association 25(2): 87-97
Okano, M.; Ohtake, T.; Saji, S. 2016: Combination Therapy of Molecular-Targeted Drugs for Breast Cancer -- their Potential in the Future Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(4): 398-403
Kieslich, K. 1986: Production of drugs by microbial biosynthesis and biotransformation. Possibilities, limits and future developments (2nd communication) Arzneimittel-Forschung 36(5): 888-892
Eleti, S. 2016: Drugs in Alzheimer's disease Dementia: An overview of current pharmacological management and future directions Psychiatria Danubina 28(Suppl-1): 136-140
Atsmon, A.; Blum, I. 1978: Beta-adrenergic blocking drugs in psychiatry: present status, future approaches and research L'Encephale 4(2): 173-186
Hammett, T.M.; Parsons, D.S. 2014: Evaluation of HIV prevention interventions for people who inject drugs in low- and middle-income countries--the current and future state of the art International Journal on Drug Policy 25(3): 336-339
Springer, S.A.; Larney, S.; Alam-Mehrjerdi, Z.; Altice, F.L.; Metzger, D.; Shoptaw, S. 2015: Drug Treatment as HIV Prevention Among Women and Girls Who Inject Drugs From a Global Perspective: Progress, Gaps, and Future Directions Journal of Acquired Immune Deficiency Syndromes 69 Suppl. 2: S155-S161
Jaillon, P. 1986: Current therapeutic concepts in the treatment of myocardial ischemia. Current and future drugs Annales de Cardiologie et d'Angeiologie 35(7 Pt 2): 453-458
Shanahan, D. 2012: A different kind of 'normal' Journal of Wound Care 21(8): 355
Myers, K.J. 1989: More research, yes! but what kind? Journal of the American Optometric Association 60(11): 815-819
Chapman, S. 1992: A '90s kind of leader Radiology Management 14(2): 61-63